Kim E - Search Results

1

Four-year biochemical outcome after radioimmunoguided transperineal brachytherapy for patients with prostate adenocarcinoma.

Ellis RJ, Vertocnik A, Kim E, Zhou H, Young B, Sodee B, Fu P, Beddar S, Colussi V, Spirnak JP, Dinchman KH, Resnick M, Kinsella TJ. Ellis RJ, et al. Among authors: kim e. Int J Radiat Oncol Biol Phys. 2003 Oct 1;57(2):362-70. doi: 10.1016/s0360-3016(03)00588-1. Int J Radiat Oncol Biol Phys. 2003. PMID: 12957246

2

Radioimmunoguided imaging of prostate cancer foci with histopathological correlation.

Ellis RJ, Kim EY, Conant R, Sodee DB, Spirnak JP, Dinchman KH, Beddar S, Wessels B, Resnick MI, Kinsella TJ. Ellis RJ, et al. Among authors: kim ey. Int J Radiat Oncol Biol Phys. 2001 Apr 1;49(5):1281-6. doi: 10.1016/s0360-3016(00)01582-0. Int J Radiat Oncol Biol Phys. 2001. PMID: 11286835

3

Brachytherapy: update and results.

Ellis RJ, Kim E. Ellis RJ, et al. Among authors: kim e. Curr Urol Rep. 2003 Jun;4(3):233-9. doi: 10.1007/s11934-003-0075-2. Curr Urol Rep. 2003. PMID: 12756088 Review.

4

Quality of coverage: conformity measures for stereotactic radiosurgery.

Wu QR, Wessels BW, Einstein DB, Maciunas RJ, Kim EY, Kinsella TJ. Wu QR, et al. Among authors: kim ey. J Appl Clin Med Phys. 2003 Autumn;4(4):374-81. doi: 10.1120/jacmp.v4i4.2506. J Appl Clin Med Phys. 2003. PMID: 14604427 Free PMC article.

5

Intraoperative radiotherapy in the multimodality approach to bone and soft tissue cancers.

Ellis RJ, Kim E, Kinsella TJ, Eisenberg BL. Ellis RJ, et al. Among authors: kim e. Surg Oncol Clin N Am. 2003 Oct;12(4):1015-29. doi: 10.1016/s1055-3207(03)00095-4. Surg Oncol Clin N Am. 2003. PMID: 14989130 Review.

6

Combination conformal radiotherapy and radioimmunoguided transperineal 103Pd implantation for patients with intermediate and unfavorable risk prostate adenocarcinoma.

Ellis RJ, Vertocnik A, Sodee B, Zhou H, Kim E, Young B, Fu P, Colussi V, Spirnak JP, Dinchman KH, Resnick MI. Ellis RJ, et al. Among authors: kim e. Brachytherapy. 2003;2(4):215-22. doi: 10.1016/j.brachy.2003.12.002. Brachytherapy. 2003. PMID: 15062129

7

Role of ProstaScint for brachytherapy in localized prostate adenocarcinoma.

Ellis RJ, Kim E, Foor R. Ellis RJ, et al. Among authors: kim e. Expert Rev Mol Diagn. 2004 Jul;4(4):435-41. doi: 10.1586/14737159.4.4.435. Expert Rev Mol Diagn. 2004. PMID: 15225091

8

Biochemical disease-free survival rates following definitive low-dose-rate prostate brachytherapy with dose escalation to biologic target volumes identified with SPECT/CT capromab pendetide.

Ellis RJ, Zhou H, Kim EY, Fu P, Kaminsky DA, Sodee B, Colussi V, Vance WZ, Spirnak JP, Kim C, Resnick MI. Ellis RJ, et al. Brachytherapy. 2007 Jan-Mar;6(1):16-25. doi: 10.1016/j.brachy.2006.11.002. Brachytherapy. 2007. PMID: 17284381 Clinical Trial.

9

Rectal morbidity after permanent prostate brachytherapy with dose escalation to biologic target volumes identified by SPECT/CT fusion.

Ellis RJ, Zhou H, Kaminsky DA, Fu P, Kim EY, Sodee DB, Colussi V, Spirnak JP, Whalen CC, Resnick MI. Ellis RJ, et al. Brachytherapy. 2007 Apr-Jun;6(2):149-56. doi: 10.1016/j.brachy.2007.01.006. Brachytherapy. 2007. PMID: 17434109

10

A phase II study of radiotherapy and concurrent paclitaxel chemotherapy in breast-conserving treatment for node-positive breast cancer.

Chen WC, Kim J, Kim E, Silverman P, Overmoyer B, Cooper BW, Anthony S, Shenk R, Leeming R, Hanks SH, Lyons JA. Chen WC, et al. Among authors: kim e, kim j. Int J Radiat Oncol Biol Phys. 2012 Jan 1;82(1):14-20. doi: 10.1016/j.ijrobp.2010.08.051. Epub 2010 Oct 29. Int J Radiat Oncol Biol Phys. 2012. PMID: 21035961 Clinical Trial.

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Article Language

Species

Sex

Age

Other

23,617 results

Search Page

Filters